POINT BIOMEDICAL Trademark
Trademark Overview
On Wednesday, April 29, 1998, a trademark application was filed for POINT BIOMEDICAL with the United States Patent and Trademark Office. The USPTO has given the POINT BIOMEDICAL trademark a serial number of 75476722. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Saturday, September 8, 2001. This trademark is owned by Point Biomedical Corporation. The POINT BIOMEDICAL trademark is filed in the Advertising, Business and Retail Services and Treatment & Processing of Materials Services categories with the following description:
Marketing and advertising services for the goods of others, namely, biodegradable collagen polymers designed to function as a diagnostic contrast agent and as an adjuvant and which deliver a variety of drugs and diagnostic agents to specific sites in the body; technology licensing services in the fields of diagnostic imaging, therapy and in vivo drug delivery
Custom manufacturing of biodegradable collagen polymers designed to function as a diagnostic contrast agent and as an adjuvant, and to deliver a variety of drugs and diagnostic agents to specific sites in the body
General Information
| Serial Number | 75476722 |
| Word Mark | POINT BIOMEDICAL |
| Filing Date | Wednesday, April 29, 1998 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Saturday, September 8, 2001 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 14, 1999 |
Trademark Statements
| Disclaimer with Predetermined Text | "BIOMEDICAL" |
| Goods and Services | Marketing and advertising services for the goods of others, namely, biodegradable collagen polymers designed to function as a diagnostic contrast agent and as an adjuvant and which deliver a variety of drugs and diagnostic agents to specific sites in the body; technology licensing services in the fields of diagnostic imaging, therapy and in vivo drug delivery |
| Goods and Services | Custom manufacturing of biodegradable collagen polymers designed to function as a diagnostic contrast agent and as an adjuvant, and to deliver a variety of drugs and diagnostic agents to specific sites in the body |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 10, 1998 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 10, 1998 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Point Biomedical Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Carlos, CA 94070 |
| Party Name | Point Biomedical Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Carlos, CA 94070 |
Trademark Events
| Event Date | Event Description |
| Thursday, March 21, 2002 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, March 27, 2001 | EXTENSION 2 GRANTED |
| Friday, March 2, 2001 | EXTENSION 2 FILED |
| Wednesday, August 2, 2000 | EXTENSION 1 GRANTED |
| Wednesday, May 31, 2000 | EXTENSION 1 FILED |
| Tuesday, March 7, 2000 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 14, 1999 | PUBLISHED FOR OPPOSITION |
| Friday, November 12, 1999 | NOTICE OF PUBLICATION |
| Friday, August 27, 1999 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 25, 1999 | EXAMINER'S AMENDMENT MAILED |
| Tuesday, January 5, 1999 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 5, 1999 | NON-FINAL ACTION MAILED |
| Tuesday, November 24, 1998 | ASSIGNED TO EXAMINER |
